Neoscreen Ltd. is an ISO 15189 and 17025 accredited
laboratory, for performing molecular diagnostic tests, that
has specialized in Clinical Genetic tests since 2007.
Its expertise includes Carrier Screening, Cancer Predisposition, Expanded Newborn Screening, Whole Exome and Whole Genome Sequencing.
Neoscreen long standing expertise in genetic testing has been added up to its flexibility to adapt to frequent changes and needs from the medical community to updated panels and tests to improve diagnosis.